Concepedia

Craig Mallinckrodt

CM

Statistics

Publications

95

Citations

9.5K

H-Index

45

Active since

1993

Affiliations

Eli Lilly (United States)(Current)

Colorado State University

Hasselt University

Indiana University – Purdue University Indianapolis

KU Leuven

Craig Mallinckrodt is an author at Eli Lilly (United States) specializing in medicine, psychopharmacology, and clinical pharmacology.

Publications per year

1993–2025

95

Publications

95

Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease

Samantha Budd Haeberlein, Paul Aisen, Frederik Barkhof et al. · The Journal of Prevention of Alzheimer s Disease · 2022 · 1.3K citations · Full text

Medicine, Neurology, Pharmacology +17

Low mechanical signals strengthen long bones

Clinton T. Rubin, A. Simon Turner, Steven D. Bain et al. · Nature · 2001 · 717 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +13

Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia

Anantha Shekhar, William Z. Potter, Jeffrey Lightfoot et al. · American Journal of Psychiatry · 2008 · 559 citations

Medicine, Pharmacology, Psychiatry +17

ACCOUNTING FOR DROPOUT BIAS USING MIXED-EFFECTS MODELS

Craig Mallinckrodt, W. Scott Clark, S.R. David · Journal of Biopharmaceutical Statistics · 2001 · 412 citations

Public Health, Biostatistics, Causal Inference +16

Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials

Craig Mallinckrodt, P. W. Lane, Dan Schnell et al. · Drug Information Journal · 2008 · 358 citations

Public Health, Biostatistics, Clinical Epidemiology +15

1–5 of 95